
0.83 Delayed Data As of Jul 01 | ![]() Today’s Change | 0.82 Today|||52-Week Range 5.04 | -34.13% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +502.41% increase from the last price of 0.83.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since December, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.